Home › Funds › Samsara BioCapital, LLC › ALMS
Samsara BioCapital, LLC position in ALMS
ALUMIS INC · Health Care
Samsara BioCapital, LLC reported holding 7,235,809 shares of ALMS (ALUMIS INC) in its Q3 2026 13F filing — a position valued at US$53.5M, representing 5.08% of its reported portfolio and ranking #6 among its reported holdings. Samsara BioCapital, LLC has disclosed ALMS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's ALMS position evolved
Samsara BioCapital, LLC first disclosed a stake in ALMS in Q3 2024 at 3,266,498 shares (US$34.9M). The position peaked in Q2 2026 at 6,345,219 shares, worth US$178.6M. Across 9 filings, Samsara BioCapital, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 7,235,809 shares valued at US$53.5M — an increase of 890,590 shares quarter over quarter.. Notable position changes include a 47% increase in Q2 2025 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3.27M | $34.89M | New |
| Q4 2024 | 3.27M | $25.67M | Hold |
| Q1 2025 | 3.27M | $20.06M | Hold |
| Q2 2025 | 4.80M | $14.40M | Add |
| Q3 2025 | 4.80M | $19.16M | Hold |
| Q4 2025 | 5.76M | $56.19M | Add |
| Q1 2026 | 6.35M | $139.79M | Add |
| Q2 2026 | 6.35M | $178.55M | Hold |
| Q3 2026 | 7.24M | $53.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALMS and 13F data
ALMS (ALUMIS INC) is a Health Care company. 48 other funds we track also report a position in ALMS — the largest reported positions include AyurMaya Capital Management Company, LP (US$111.9M), Deep Track Capital, LP (US$55.2M), Foresite Capital Management V, LLC (US$43.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALMS
- AyurMaya Capital Management Company, LP 15.14M sh · $111.88M · Q3 2026
- Deep Track Capital, LP 7.47M sh · $55.20M · Q3 2026
- Foresite Capital Management V, LLC 5.90M sh · $43.58M · Q3 2026
- Nextech Invest Ltd. 4.55M sh · $33.63M · Q3 2026
- Foresite Capital Management VI LLC 4.25M sh · $31.39M · Q3 2026
- venBio Partners LLC 4.19M sh · $30.97M · Q3 2026
- Saturn V Capital Management LP 2.86M sh · $21.10M · Q3 2026
- Opaleye Management Inc. 550.00K sh · $15.48M · Q2 2026
- Cormorant Asset Management, LP 2.08M sh · $15.33M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.96M sh · $14.48M · Q3 2026
- Novo Holdings A/S 1.25M sh · $9.24M · Q3 2026
- Logos Global Management LP 1.00M sh · $7.39M · Q3 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held ALMS?
Samsara BioCapital, LLC has disclosed ALMS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Samsara BioCapital, LLC's current position in ALMS?
As of Q3 2026, Samsara BioCapital, LLC holds 7.24M shares of ALMS (ALUMIS INC), valued at $53.47M, representing 5.08% of its reported portfolio and ranking #6.
Has Samsara BioCapital, LLC been buying or selling ALMS?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC increased its position in ALMS. The position peaked in Q2 2026 at 6.35M shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Foresite Capital Management V, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.